文献速递哮喘

既往吸烟暴露对重症哮喘患者气道嗜酸性粒细胞活化及自身免疫的影响

Impact of former smoking exposure on airway eosinophilic activation and autoimmunity in patients with severe asthma.
PubMed 文献 · Eur Respir J · 2022-10-06

该研究纳入132例重症哮喘患者,按吸烟史≥10包年与<10包年分组,比较痰嗜酸性粒细胞炎症、活化标志物及自身抗体。结果显示≥10包年组嗜酸性气道炎症更常见(66.7% vs 38.7%,p=0.03),游离嗜酸性粒细胞颗粒及抗EPX、抗MARCO抗体水平更高,且泼尼松龙治疗后痰嗜酸性粒细胞仅部分降低。

要点

  • 重症哮喘中既往吸烟≥10包年与嗜酸性气道炎症及活化相关
  • 既往吸烟者气道抗EPX和抗MARCO自身抗体水平升高
  • ≥10包年吸烟史患者对泼尼松龙反应相对不敏感

核心结论

  • 重症哮喘患者中,既往吸烟史与嗜酸性气道炎症、活化及相对激素不敏感相关,并涉及气道自身免疫。

研究设计与样本

  • 研究纳入132例符合ERS/ATS标准的重症哮喘患者,采集痰标本进行细胞分类计数并检测游离嗜酸性粒细胞颗粒、抗EPX及抗MARCO抗体,其中嗜酸性气道炎症亚组在泼尼松龙治疗2周后复评。

主要发现

  • 39例(29.5%)患者吸烟史≥10包年,其中36例(27.3%)为既往吸烟者,3例(2.3%)为当前吸烟者;93例(70.5%)吸烟暴露<10包年。
  • ≥10包年组嗜酸性气道炎症比例为66.7%,高于<10包年组的38.7%(p=0.03)。
  • ≥10包年组游离嗜酸性粒细胞颗粒水平更高(p=0.001),抗EPX和抗MARCO抗体水平亦更高(分别为p<0.05和p<0.0001)。
  • 排除当前吸烟者后上述关联仍存在。
  • 在≥10包年吸烟史患者中,泼尼松龙降低但未使痰嗜酸性粒细胞恢复正常。

临床怎么用

  • 对重症哮喘患者应详细采集吸烟史(包年),既往吸烟≥10包年者需关注嗜酸性气道炎症及自身免疫指标。
  • 既往吸烟≥10包年的重症哮喘患者即使接受激素治疗,痰嗜酸性粒细胞可能未完全控制,需警惕相对激素不敏感。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Severe eosinophilic asthma is characterised by frequent exacerbations and a relative insensitivity to steroids. Experimentally, smoking may induce eosinophilic airway inflammation, but the impact in patients with severe asthma is not clear. OBJECTIVE: To investigate the association between smoking exposure in patients with severe asthma, and eosinophilic inflammation and activation, as well as airway autoimmunity and steroid responsiveness. METHODS: Patients with severe asthma according to European Respiratory Society/American Thoracic Society criteria were assessed with sputum samples, analysed by cell differential count, and for the presence of free eosinophil granules (FEGs), autoantibodies against eosinophil peroxidase (EPX) and macrophage receptor with collagenous structure (MARCO). A subgroup of patients with eosinophilic airway inflammation was re-assessed after a 2-week course of prednisolone. RESULTS: 132 severe asthmatics were included in the study. 39 (29.5%) patients had ≥10 pack-years of smoking history: 36 (27.3%) were former smokers and three (2.3%) current smokers; and 93 (70.5%) had <10 pack-years exposure. Eosinophilic airway inflammation was more prevalent among patients with ≥10 pack-years (66.7%), compared to patients with <10 pack-years (38.7%, p=0.03), as was the level of FEGs (p=0.001) and both anti-EPX and anti-MARCO (p<0.05 and p<0.0001, respectively). Omitting current smokers did not affect these associations. Furthermore, prednisolone reduced, but did not normalise, sputum eosinophils in patients with a ≥10 pack-year smoking history. CONCLUSION: In patients with severe asthma, a former smoking history is associated with eosinophilic airway inflammation and activation and relative insensitivity to steroids, as well as airway autoimmunity.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Klein DK, Silberbrandt A, Frøssing L, et al. Impact of former smoking exposure on airway eosinophilic activation and autoimmunity in patients with severe asthma. Eur Respir J. 2022. PMID: 35236724. doi:10.1183/13993003.02446-2021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。